Under construction – not a live service
Sign in
Taking people in FranceNo phase

Studying False-Positive HLA Antibody Test Results in People With Systemic Lupus Erythematosus

Looks at false-positive HLA antibody tests in adults with systemic lupus erythematosus.

Plain-language title generated from the registry record
Registry title: HLA Antibodies in Systemic Lupus Erythematosus

Key facts

Where
Amiens, FranceSee the site

Where in France

  • CHRU AmiensAmiens, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier Universitaire, Amiens
Trial code
NCT06921239
Record updated
16 January 2026
Original description
Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.Read full original descriptionShow less

HLA Antibodies in Systemic Lupus Erythematosus

Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.

Inclusion: Patients Adults; Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus; Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants); With sera stored in the biobank.

Exclusion: minor Patients; Opposing the re-use of their personal data for research purposes.

ClinicalTrials.gov NCT06921239